The emerging field of epigenetics in neurodegeneration and neuroprotection

被引:240
|
作者
Hwang, Jee-Yeon [1 ]
Aromolaran, Kelly A. [1 ]
Zukin, R. Suzanne [1 ]
机构
[1] Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, Rose F Kennedy Ctr, Room 610,1300 Morris Pk Ave, Bronx, NY 10461 USA
基金
美国国家卫生研究院;
关键词
RUBINSTEIN-TAYBI-SYNDROME; TRANSCRIPTION FACTOR REST; SCF-BETA-TRCP; SUBEROYLANILIDE HYDROXAMIC ACID; HISTONE DEACETYLASE INHIBITION; GENOME-WIDE ANALYSIS; LONG NONCODING RNA; ALZHEIMERS-DISEASE; DNA METHYLATION; HUNTINGTONS-DISEASE;
D O I
10.1038/nrn.2017.46
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Epigenetic mechanisms - including DNA methylation, histone post-translational modifications and changes in nucleosome positioning - regulate gene expression, cellular differentiation and development in almost all tissues, including the brain. In adulthood, changes in the epigenome are crucial for higher cognitive functions such as learning and memory. Striking new evidence implicates the dysregulation of epigenetic mechanisms in neurodegenerative disorders and diseases. Although these disorders differ in their underlying causes and pathophysiologies, many involve the dysregulation of restrictive element 1-silencing transcription factor (REST), which acts via epigenetic mechanisms to regulate gene expression. Although not somatically heritable, epigenetic modifications in neurons are dynamic and reversible, which makes them good targets for therapeutic intervention.
引用
收藏
页码:347 / 361
页数:15
相关论文
共 50 条
  • [31] Tryptophan, adenosine, neurodegeneration and neuroprotection
    T. W. Stone
    C. M. Forrest
    G. M. Mackay
    N. Stoy
    L. G. Darlington
    Metabolic Brain Disease, 2007, 22 : 337 - 352
  • [32] Neurodegeneration and Neuroprotection in Multiple Sclerosis
    Stangel, Martin
    CURRENT PHARMACEUTICAL DESIGN, 2012, 18 (29) : 4471 - 4474
  • [33] Neurodegeneration and neuroprotection in multiple sclerosis
    Davydovskaya, M. V.
    Boyko, A. N.
    Gusev, E. I.
    ZHURNAL NEVROLOGII I PSIKHIATRII IMENI S S KORSAKOVA, 2009, 109 (07) : 44 - 52
  • [34] Lipid Rafts in Neurodegeneration and Neuroprotection
    Sonnino, Sandro
    Aureli, Massimo
    Grassi, Sara
    Mauri, Laura
    Prioni, Simona
    Prinetti, Alessandro
    MOLECULAR NEUROBIOLOGY, 2014, 50 (01) : 130 - 148
  • [35] Neurodegeneration and neuroprotection in the epileptic brain
    Chrysanthy Ikonomidou
    Annals of General Psychiatry, 7 (Suppl 1)
  • [36] Innate immunity: neuroprotection or neurodegeneration?
    Rivest, S
    JOURNAL OF NEUROIMMUNOLOGY, 2004, 154 (1-2) : 6 - 6
  • [37] Lipid Rafts in Neurodegeneration and Neuroprotection
    Sandro Sonnino
    Massimo Aureli
    Sara Grassi
    Laura Mauri
    Simona Prioni
    Alessandro Prinetti
    Molecular Neurobiology, 2014, 50 : 130 - 148
  • [38] Epigenetics: An emerging field in the pathogenesis of nonalcoholic fatty liver disease
    Ashraf, Nissar U.
    Altar, Mohammad
    MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH, 2018, 778 : 1 - 12
  • [39] Epigenetics and therapeutic targets mediating neuroprotection
    Qureshi, Irfan A.
    Mehler, Mark F.
    BRAIN RESEARCH, 2015, 1628 : 265 - 272
  • [40] Epigenetics in neurodegeneration: A new layer of complexity
    Marques, Sueli C. F.
    Oliveira, Catarina R.
    Pereira, Claudia M. F.
    Outeiro, Tiago F.
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2011, 35 (02): : 348 - 355